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064 The Journal of Thoracic and Cardbjective: This study was undertaken to determine long-term clinical and echocar-
iographic outcomes after the Konno procedure.
ethods: Fifty-three patients who underwent the Konno procedure between
anuary 1, 1980, and January 1, 2004, were reviewed.
esults: Mean age at operation was 19 years (range, 1-65 years). Indications
ere as follows: complex subaortic or tunnel stenosis in 22 (41%), multilevel
eft ventricular outflow tract obstruction in 20 (38%), and aortic valve stenosis or
ypoplasia in 11 (21%). Before the Konno procedure, 66 operations were performed
n 41 (77%) patients. Thirty-three (62%) patients had greater than New York Heart
ssociation class I symptoms preoperatively. A mechanical aortic valve was im-
lanted in 40 (75%), a homograft in 10 (19%), and a xenograft prosthesis in 3 (6%).
ortality at 30 days was 8% (n  4). Survival at 10 years was 86%. Risk factors
or overall mortality were New York Heart Association class (hazard ratio 2.22, P
04) and longer bypass time (hazard ratio 1.93/hour, P  .04). The cumulative
robability of aortic valve reoperation was 19% at 5 years and 39% at 10 years,
ccurring in 15 patients at a median of 3.8 years. The average left ventricular
utflow tract mean gradients were 19 mm Hg at 1 year (n  9), 13 mm Hg at 1
o 3 years (n  9), and 13 mm Hg at 3 to 5 years (n  5). Pulmonary regurgitation
as detected in 6 patients. Pulmonary valve replacement was performed in 3 (6%).
t the date of last contact, all patients for whom data was available were in New
ork Heart Association functional class I or II.
onclusion: The Konno procedure is effective, allowing both long-term reduction of
eft ventricular outflow tract obstruction and improvement in functional class. Prosthetic
ortic valve and native pulmonary valve complications may necessitate reoperation.
 
he surgical management of simple left ventricular outflow tract obstru
(LVOTO) confined to discrete subvalvular,1-8 valvular,9,10 or supravalvu-
lar11-14 levels has been well described in the literature. Complex LV
nvolving two or more levels of the outflow tract is a unique problem for which
pecific procedures have evolved. The aortoventriculoinfundibuloplasty (Konno
rocedure), described contemporaneously by both Konno and colleagues15 and
astan and Koncz,16 was initially devised as an alternative to the apicoaortic co
or the treatment of tunnel subaortic stenosis. The original description involved
atch enlargement of both the left and right outflow tracts and the insertion of a
echanical aortic valve prosthesis.15,16 The Konno procedure has subsequent
merged as the procedure of     multilevel LVOTO, particularly
hose with a small aortic annulus.17-22 The original technique of valve replaceme
as broadened recently to include biologic aortic prostheses.23-27
Although several studies have examined the midterm results of the Konno
rocedure, there are few data regarding the long-term results obtained for these
iovascular Surgery ● November 2006
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Datients. Moreover, the effects on left ventricular size and
unction after elimination of LVOTO remain unclear. The
ncision across the aortic annulus during the Konno proce-
ure approaches both the conduction system and the native
ulmonary valve. Although the risk of heart block has been
ocumented in the literature, there is little information re-
arding native pulmonary valve function after this opera-
ion. The purpose of this study was to review the long-term
esults of the Konno procedure, including patient survival,
eoperation risk, pulmonary valve complications, and ef-
ects on left ventricular size and function.
ethods
he records of 53 patients with complex LVOTO who underwent
he Konno procedure at the Mayo Clinic Rochester between Jan-
ary 1, 1980, and January 1, 2004, were reviewed. The study was
pproved by the Mayo Clinic College of Medicine Institutional
eview Board. Excluded from analysis were 5 other patients who
nderwent the Ross-Konno procedure. Three of those patients had
modified Konno procedure performed, involving septal patch
nlargement of left ventricular outflow tract obstruction, before the
tandard Konno procedure. One patient underwent the first Konno
rocedure elsewhere and required a reoperative Konno procedure
t our institution to correct recurrent stenosis at the valvular and
ubvalvular levels.
Demographic, morphologic, echocardiographic, and surgical
ata were obtained from hospital records, and a prospectively
ccrued SAS (SAS Institute, Inc, Cary, NC) database. There were
early (30 days or in-hospital) and 7 late deaths. Recent cross-
ectional follow-up was obtained through the Mayo Survey Re-
earch Center by means of telephone calls and written correspon-
ence. Ten patients were unavailable for follow-up or refused
urther questionnaires; their last observed episodes were used for
alculation purposes. The mean (SD) duration of follow-up for
arly survivors was 8.2  5.7 years (range 14 days-22 years).
here are currently 42 patients still alive, and current follow-up
as available for 32 of them.
Echocardiographic data were obtained from the medical records
nd through contact with outside physicians. All gradients are re-
orted as means and measured in millimeters of mercury. Ejection
raction and left ventricular end-diastolic and end-systolic dimen-
ions were recorded as available.
tatistical Analysis
urvival and reoperation probabilities and 95% confidence inter-
als were computed with the Kaplan-Meier method (actuarial).
he prognostic significances of potential risk factors were tested
Abbreviations and Acronyms
LVOTO left ventricular outflow tract obstruction
PR  pulmonary regurgitation
PVR  pulmonary valve replacementith the Cox proportional hazards models. q
The Journal of Thoracicesults
aseline characteristics for the 53 patients included in the
tudy are summarized in Table 1. The age range at ope
as 1 to 65 years. Most patients were in normal sinus rhythm
efore the operation, had minimal symptoms, and underwent
peration after 1990. Before the Konno procedure, 41 patients
ad undergone 70 previous cardiovascular interventions (Ta
). Twenty-two patients (42%) had a second operation be
he Konno procedure, and 7 (13%) had a third. Indications for
he Konno procedure are described in Table E1. The 
requent reason for operation was to correct multilevel
VOTO (n 23, 43%), followed by complex subaortic tunnel
tenosis (n  18, 34%) and valvular anomalies with annular
ypoplasia (n  12, 23%).
The technical aspects of the Konno procedure are sum-
arized in Table E2. As described in the classic descri
f the procedure,15 a mechanical valve was inserted in m
ases (n  40, 75%). This was followed in frequency by a
omograft (n 10, 19%) and, finally, a xenograft prosthesis
n  3, 6%). The septal patch was constructed most fre-
ABLE 1. Baseline characteristics
ge (y, mean with range) 19 (1-65)
ge (No.)
1 y 0
1-10 20 (38%)
10 33 (62%)
ex (No.)
Male 27 (51%)
Female 26 (49%)
hythm (No.)
Sinus 52 (98%)
Paced 1 (2%)
YHA functional class (No.)
I 20 (38%)
II 30 (57%)
III 2 (4%)
IV 1 (2%)
reoperative echocardiography
Mean aortic gradient (mm Hg,
mean with range, n  25)
51 (12-87)
Ejection fraction (%, mean with range,
n  50)
66% (15%-89%)
LVEDD (%, mean with range, n  40) 44% (18%-92%)
LVESD (%, mean with range, n  40) 25% (6%-84%)
Regurgitation (No., n  41)
0-1 6 (15%)
2 7 (17%)
3 14 (34%)
4 14 (34%)
peration before 1990 (No.) 37 (70%)
YHA, New York Heart Association; LVEDD, left ventricular end-diastolic
imension; LVESD, left ventricular end-systolic dimension.uently with untreated Dacron polyester fabric (n  30,
and Cardiovascular Surgery ● Volume 132, Number 5 1065
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D7%), whereas the remaining patients had pericardium,
eadox (Meadox Medicals, Oakland, NJ), Tascon (Tas-
on Industries, Houston, Tex), homograft, or polytetra-
uoroethylene (Gore-Tex; W. L. Gore & Associates, Inc,
lagstaff, Ariz). The right ventricular outflow tract recon-
truction was most often performed with a bovine or autol-
gous pericardial patch (n  39, 74%), and care was taken
o avoid damaging the pulmonary valve. Concomitant pro-
edures included mitral valve replacement (n  4, 8%),
itral valve repair (n  3, 6%), tricuspid valve repair (n 
, 4%), ventricular septal defect closure (n  2, 4%),
oronary artery bypass grafting (n 2, 4%), and permanent
acemaker insertion (n  1, 2%). Median bypass time was
73 minutes, and median crossclamp time was 114 minutes.
onfatal complications included complete heart block re-
uiring placement of a permanent pacemaker in 6 patients
11%), sepsis in 2 (4%), and bleeding, respiratory failure,
nd renal failure in 1 patient each.
Actuarial survival is shown in Figure 1. Early mort
as 8% (n  4), whereas 5- and 10-year survivals were
7% and 86%, respectively. Univariate analysis of risk
actors for mortality revealed only preoperative New York
eart Association functional class (hazard ratio 2.22, P 
ABLE 2. Previous cardiovascular operations
peration First Second Third
esection subaortic ridge 10 (19%) 3 (6%) 3 (6%)
alvotomy 9 (17%) 3 (6%)
oarctation repair 6 (11%)
VR 4 (8%) 3 (6%) 2 (4%)
yectomy 3 (6%)
AVC 3 (6%)
AA 2 (4%)
AVC 1 (2%) 1 (2%)
A band 1 (2%)
ortic repair 1 (2%)
oss procedure 1 (2%)
VR 3 (6%)
odified Konno 3 (6%)
picoaortic conduit 2 (4%)
ortic root replacement 1 (2%)
DA ligation 1 (2%)
V repair 1 (2%)
SD closure 1 (2%)
onno procedure 1 (2%)
ericardiectomy 1 (2%)
ata are numbers and percentages of patients. AVR, aortic valve replace-
ent; PAVC, partial anomalous venous connection; CAVC, complete atrio-
entricular canal defect; PA, pulmonary artery; IAA, interrupted aortic
rch; MVR, mitral valve replacement; Modified Konno, patch enlargement
ubarterial septum; PDA, patent ductus arteriosus; MV, mitral valve; VSD,
entricular septal defect.04) and longer bypass times (hazard ratio 1.93/h, P  .04) s
066 The Journal of Thoracic and Cardiovascular Surgery ● Novs predictive (Table 3). The number of events was in
ient for multivariate modeling.
Sixteen aortic reoperations were performed in 15 pa-
ients, at a mean (SD) of 5 years  4.4 after the Konno
igure 1. Kaplan-Meier freedom from death after Konno procedure
ersus time. Zero time on abscissa represents date of operation.
umbers at bottom of figure denote actuarial survivals (%) and
umbers of patients at risk (N) at 2-year intervals.
ABLE 3. Univariate predictors of mortality
ariable
Hazard
ratio P value
ge 1.00 .86
emale sex 1.46 .53
SA 1.92 .32
YHA functional class 2.22 .04
ndication for Konno
Tunnel subaortic 0.81 .76
Multilevel 3.11 .08
AS, AR, annular hypoplasia 0.21 .14
reoperative AR (n  41) 0.75 .42
reoperative AS, mean gradient (n  25) 1.02 .51
reoperative ejection fraction (n  50) 0.97 .19
reoperative LVEDD (n  40) 0.95 .35
reoperative LVESD (n  40) 1.03 .36
ypass 1.93/h .04
rossclamp 1.01 .51
peration 1990 or later vs before 1990 0.51 .28
alve type
Xenograft NA NA
Mechanical 1.37 .69
Homograft 0.92 .91
alve size 1.08 .45
ther previous operation 1.17 .84
ther concurrent operation 1.35 .66
SA, Body surface area; NYHA, New York Heart Association; AS, aortic
tenosis; AR, aortic regurgitation; LVEDD, left ventricular end-diastolic dimen-
ion; LVESD, left ventricular end-systolic dimension; NA, not applicable.
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Drocedure (Figure 2). Of these, 11 patients had a mecha
alve, 3 had homografts, and 1 had a xenograft bioprosthe-
is. Indications for aortic reoperation (Table E3) inclu
alve stenosis (n  6, 11%), regurgitation (n  5, 9%), and
ndocarditis (n  3, 6%). A larger prosthesis was placed at
eoperation in all but 1 patient, in whom the cause of
tenosis was subprosthetic pannus. No patients undergoing
he Konno procedure at our institution required reoperation
or recurrent subvalvular obstruction. The hazard phase for
ortic reoperation was relatively constant after the Konno
rocedure, with 5- and 10-year survivals free of reoperation
f 81% and 61%, respectively. The linearized risk of aortic
eoperation was 3.9%/y. Among the 6 patients requiring
eoperation for aortic valve stenosis, a mechanical prosthe-
is had been placed during the Konno procedure in 4, a
omograft in 1, and a xenograft in 1. In all cases but 1, a
arger size prosthesis was implanted at reoperation.
Causes of nonaortic reoperation were as follows: closure
f a residual ventricular septal defect (n  3, 6%), pulmo-
ary valve replacement (PVR, n  3, 6%), mitral valve
eplacement (n  2, 4%), tricuspid valve replacement (n 
, 4%), and heart transplantation (n  1, 2%). The only
nivariate factor predictive of a decreased risk for aortic
eoperation was correction of tunnel subaortic stenosis
Table 4). In contrast, an operative indication of ann
ypoplasia in conjunction with valvular stenosis or regur-
itation was a risk factor for reoperation. The number of
vents was insufficient for construction of a multivariate
odel.
The presence of echocardiographically documented pul-
onary regurgitation (PR) was found in 6 patients (n  5
evere and n  1 mild-moderate). PVR was performed in 3
igure 2. Kaplan-Meier freedom from aortic valve reoperation
fter Konno procedure versus time. Zero time on abscissa repre-
ents date of operation. Numbers at bottom of figure denote
reedoms from aortic valve reoperation (%) and numbers of pa-
ients at risk (N) at 2-year intervals.atients at a mean (SD) of 2.1 3.5 years after the Konno o
The Journal of Thoracicl
rocedure. The actuarial freedom from pulmonary compli-
ations (PR or PVR) is shown in Figure 3, demonstrat
azard phase beginning early after the Konno procedure and
ontinuing with time. The cumulative incidence of pulmo-
ary complications at 10 years was 16%.
ABLE 4. Univariate predictors of aortic valve reoperation
ariable
Hazard
ratio P value
ge 0.97 .13
emale sex 0.67 .46
SA 0.45 .17
YHA functional class 0.60 .29
ndication for Konno
Tunnel subaortic 0.11 .03
Multilevel 0.97 .95
AS, AR, annular hypoplasia 4.55 .004
reoperative AR (n  41) 0.77 .34
reoperative AS, mean gradient (n  25) 0.99 .6
reoperative ejection fraction (n  50) 1.02 .65
reoperative LVEDD (n  40) 1.01 .81
reoperative LVESD (n  40) 1.04 .48
peration 1990 or later vs before 1990 2.16 .25
alve type
Xenograft 1.24 .84
Mechanical 0.82 .74
Homograft 1.17 .81
alve size 0.87 .15
ther previous operation 1.46 .62
ther concurrent operation 0.73 .63
SA, Body surface area; NYHA, New York Heart Association; AS, aortic
tenosis; AR, aortic regurgitation; LVEDD, left ventricular end-diastolic
imension; LVESD, left ventricular end-systolic dimension.
igure 3. Kaplan-Meier freedom from pulmonary valve complica-
ions (pulmonary regurgitation or pulmonary valve replacement)
fter Konno procedure versus time. Zero time on abscissa repre-
ents date of operation. Numbers at bottom of figure denote
reedoms from pulmonary valve complications (%) and numbers
f patients at risk (N) at 2-year intervals.
and Cardiovascular Surgery ● Volume 132, Number 5 1067
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DAmong patients who were still alive and for whom data
ere available at the date of last follow-up (n  27), all
ere reported to be in New York Heart Association
unctional class I or II, and none had moderate or severe
ymptoms (functional class III or IV). Echocardiographic
ollow-up is presented in Table 5. The Konno proce
uccessfully diminished mean transaortic gradient from 51
m Hg preoperatively to 14 mm Hg after surgery, the effect
f which persisted during long-term follow-up.
iscussion
he proposed utility of the Konno procedure for the correc-
ion of complex LVOTO is well documented in the litera-
ure.17,21,24,28-30 Our study demonstrates that the procedu
s associated with a significant decline in LVOTO gradient,
tabilization of left ventricular function, and improvement
n functional class. Predictors of mortality included greater
reoperative symptoms and longer bypass time. The linear-
zed aortic reoperation rate was significant, 3.9% per year,
nd was increased among those in whom the procedure was
sed to correct aortic valve pathology in conjunction with
nnular hypoplasia. PR leading to reoperation was an im-
ortant complication after the Konno procedure, one that is
lso seen in those undergoing the Ross-Konno procedur31
The patients in our series had mild symptoms before the
peration, most often mixed aortic regurgitation and aortic
tenosis, as has been shown in other reports.21,24 Most
atients (79%) had previous interventions, and a significant
umber also had second (42%) and third (13%) operations
efore the Konno procedure, illustrating how difficult these
atients are to manage with traditional palliative tech-
iques aimed at relieving discrete or single-level obstruc-
ion. Similar combinations of complex left-sided obstruc-
ion treated by the Konno procedure have been reported
lsewhere.19,21,24,32 The range and frequency of most p-
perative nonfatal complications, including an 11% inci-
ence of permanent heart block, parallel the results of
thers.17,19,28 Operative mortality in our study was 8% 
ong-term survival at 10 years was 86%, again comparable
ABLE 5. Echocardiographic follow-up
ariable Preoperative Before DC <1 y 1-3 y 3-5 y
ean gradient
(mm Hg)
51 (25) 14 (30) 17 (7) 14 (7) 13 (5)
jection
fraction (%)
66 (50) 60 (37) 64 (9) 65 (9) 59 (5)
VEDD (%) 44 (40) 43 (29) 44 (9) 51 (9) 48 (3)
VESD (%) 25 (40) 27 (29) 27 (9) 27 (9) 34 (2)
alues are means; numbers in parentheses represent numbers of subjects.
VEDD, Left ventricular end-diastolic dimension; LVESD, left ventricular
nd-systolic dimension.o results reported elsewhere.17,19,28 n
068 The Journal of Thoracic and Cardiovascular Surgery ● NovMost of the patients in our series preferentially had a
echanical aortic valve prosthesis placed, consistent with
he original description of the operation.15 We excluded
rom this study those patients who underwent the Ross-
onno procedure to examine the risk to the native pulmo-
ary valve. Those who have popularized the use of the
oss-Konno procedure have suggested that the durability of
utografts plus homografts is superior to other prosthese24
comparable duration of follow-up will be necessary to
rove this point. Although we used aortic homografts for
ome patients in this study, the technical challenges associ-
ted with reoperation for homograft failure warrants that
hey be used with caution.33 The severe calcification seen 
enescent homografts is perilous both at the time of reentry
nd during mobilization of coronary ostia.
The hazard phase for aortic reoperation (Figure 2) 
he Konno procedure was relatively constant (3.9% per
ear) and is somewhat disappointing, considering that it is a
rocedure designed to offer definitive correction of complex
VOTO. The reoperative risk associated with mechanical
rostheses is related to complications of anticoagulation
nd thrombosis, endocarditis, and prosthesis obstruction by
annus. In contrast, the pattern of failure associated with
ioprostheses is more likely related to structural deteriora-
ion.21,24 The durability of implanted homografts and xe-
rafts has been surprising; as the duration since implanta-
ion lengthens, however, it is logical to expect a late hazard
hase to become apparent. The low numbers of xenografts
mplanted in this series may partially explain why they did
ot surface as a risk factor.
Of the 6 patients requiring reoperation for aortic valve
tenosis after the Konno procedure, 5 had a larger prosthesis
laced. This leads us to suspect that the evolution of patient-
rosthetic mismatch with somatic growth was an important
actor. In infants and small children, the Ross-Konno pro-
edure may be the preferred choice. In others, careful at-
ention may need to be given to maximizing prosthesis
ffective orifice area according to patient size. Increasing
ortic prosthesis dimension, however, poses a further risk of
ompromise of the native pulmonary annulus. This issue
ill be studied further.
Echocardiographic follow-up demonstrated that after
n initial postoperative decline, ejection fraction stabilized
ith time after the Konno procedure. Although it was ini-
ially suggested in the literature that biventricular incisions
ight adversely impact postoperative cardiac function, a
ecent report by Sharma and associates32 demonstrated that
he recovery of ventricular function after the Konno proce-
ure is analogous to that seen after aortic valve replacement
lone. We are cognizant of the fact that the values observed
t the last follow-up were probably affected by the small
umbers of patients available for study.
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DOur study has identified a nontrivial risk of pulmonary
omplications after the Konno procedure. This is repre-
ented by a hazard phase beginning immediately after op-
ration and continuing with time. One other study reported
he need for PVR in a patient 5 years after the Konno
rocedure for mixed PV stenosis and insufficiency.28 It has
een noted elsewhere that opening the right ventricular
utflow tract before incising the aortic annulus during the
onno procedure is important to protect both the native
ulmonary valve and the conduction tissue.19 This is th
ractice at our institution. Despite these measures, 6 patients
n our series had PR documented on follow-up echocardi-
graphy, and 3 required reoperation for PVR. The develop-
ent of PR may be related to an initial injury to the
ulmonary valve, disruption of the muscular subpulmonary
onus, or distortion of the pulmonary annulus by the right
entricular patch. It is further possible that chronic elevation
f left-sided pressures before the Konno procedure may
redispose a damaged or weakened pulmonary valve toward
rogressive deterioration with time. The ability of younger
atients to tolerate right-sided semilunar valve regurgitation
n the absence of significant left-sided obstruction may
ubsequently contribute to delayed recognition. We suggest
hat the sequela of PR can be avoided by accurate incisions
nd symmetric reconstruction of the septum at the time of
nitial operation.
linical Implications
he Konno procedure is often considered as a final avail-
ble option after initial attempts with “less invasive”
atheter-based or surgical techniques fail to relieve com-
lex LVOTO. Our data suggest that the Konno procedure
hould be used earlier in patients with less symptomatic
isease, especially those in whom an expeditious procedure
an be carried out to relieve aortic valve pathology in
onjunction with tunnel subaortic obstruction. Clinical and
chocardiographic surveillance after surgery is important to
etect aortic and pulmonary valve complications during
ong-term follow-up.
onclusion
he Konno procedure effectively relieves complex LVOTO,
esulting in preservation of left ventricular ejection fraction
nd functional class. The linearized rate of aortic reopera-
ion is 3.9% per year, which is higher than expected. The
ignificant risk of pulmonary valve complications requires
ngoing surveillance and perhaps technical modifications to
rotect the pulmonary valve complex from injury.
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iscussion
r Thomas L. Spray (Philadelphia, Pa). I congratulate Puga and
ssociates for a very large series of the Konno operation, which is
rare procedure in most centers. The midterm follow-up seems to
e, I would say midterm rather than long-term, an average of about
years. I have several questions for Dr Puga.
First, the indications for the operative procedure were divided
nto three different groups, subaortic tunnel stenosis, multilevel
VOTO, and aortic valve stenosis and hypoplasia, but there is
ften significant overlap in these particular categories. It is not
ncommon for patients to have subaortic, annular, valvular, and
upravalvular aortic obstruction, and it is not clear to me how you
hen categorized these patients into these different subgroups. For
xample, multilevel LVOTO may be equivalent to subaortic tunnel
tenosis, and it is often associated with aortic hypoplasia and valve
isease. So could you be more clear about how you categorized
ach of the patients preoperatively? Were the patients who had
ultilevel LVOTO, for example, really patients that had levels of
ubaortic stenosis that might be treated with a modified Konno
peration, and how did you decide whether to do a valve replace-
ent procedure like the Konno as opposed to a modified Konno
peration? You noted that a lot of these patients had aortic regur-
itation. So was aortic regurgitation actually the indication for
oing a more complex operation with a valve replacement?
A second question regards a surprising finding of your study,
he relatively high risk of aortic reoperation at 3.9% per year.
bout 70% of the patients had a mechanical valve prosthesis
mplanted, and aortic stenosis was the cause of about 40%, if I
alculated it right, of the reoperations. You noted that the operative
ndication of annular hypoplasia with aortic stenosis was a risk
actor for reoperation, and that came out in your multivariate
nalysis. I noted in the manuscript that prosthesis size actually s
070 The Journal of Thoracic and Cardiovascular Surgery ● Novpproached but did not quite reach significance as a risk factor for
eoperation. So is the potential reason for the reoperation rate
eing so high the fact that patients with annular hypoplasia perhaps
idn’t have a large enough patch put in the ventricular septum?
ou suggest that patients with tunnel subaortic stenosis have a
ecreased risk of reoperation, potentially related to the large septal
atch, which would tend to confirm that the septal patch may have
lot to do with this, and maybe you are undersizing the annulus at
he time of implantation. Were there other patients, for example,
ho had minimal or no septal patches placed?
Also please comment, in relation to this finding that the aortic
alve prosthesis may be somewhat small, whether those patients
hould really be considered for the Ross-Konno operation with a
oot replacement. How do you now decide whether to do a Ross-
onno versus an actual Konno operation with a mechanical pros-
hesis?
Third, the PR you saw seemed to be relatively early, although
here was a late hazard phase. Was there any attempt made to
orrelate the operative technique or the findings in the operating
oom with the development of late PR? For example, was there any
vidence of pulmonary valve injury or valve dysfunction in the
perating room or early at discharge that might suggest that this
as actually an operative damage problem, as opposed to a ge-
metry change with time that might lead to regurgitation?
Finally, you noted that there was a small decrease in the
jection fraction early after operation, which then recovered with
ime, but I noted in the manuscript that the end-diastolic and
nd-systolic dimensions didn’t change before and after surgery,
hich was somewhat surprising. If those don’t change, I can’t see
ow ejection fraction changed. In addition, if many of these
atients had significant aortic regurgitation, one would expect to
ee some change in dimension and, potentially, ejection fraction
ith time. So I wonder whether you had any evidence of regional
all motion abnormality, for example in the septum, that might
ave changed or improved through the duration of the study?
I thank you for the opportunity to discuss what I think is an
utstanding clinical series.
Dr Puga. My gratitude to Dr Spray for his willingness to
eview the manuscript in the early stages and for his questions and
omments.
In response to your first question, the classification refers to the
redominant area of obstruction in the left ventricular outflow tract
t the time of the Konno operation. Inevitably, these groups
verlap because of the complexity of the pathologic changes.
ndeed, patients may have had preliminary interventions to resolve
pecific problems and may have ended with the Konno operation
s the final solution to the problems affecting the left ventricular
utflow tract. As you suggest, some patients underwent prelimi-
ary resection of subaortic stenosis, which may have resulted in
nadequate relief or recurrence of the obstruction. Or patients may
ave had a modified Konno procedure with adequate relief of the
ubaortic obstruction but with newly appearing aortic valve steno-
is or insufficiency. Either of these scenarios in a growing child
equires the Konno procedure to allow the insertion of an adult-
ized valvular prosthesis.
In response to your second question, I must accept that there
as a relatively high incidence of reoperation because of aortictenosis. This reflects our inability to insert in a small growing
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Dhild a prosthesis that would approximate a satisfactory adult size
21 mm or larger). With the smaller prosthesis, patient-prosthesis
ismatch will inevitably develop, resulting in aortic stenosis even
n the presence of a normally functioning valve. As you suggest,
e are indeed undersizing the area of implantation of the prosthe-
is and patch necessary to complete the Konno procedure. I find
his one of the strongest limitations of the Konno operation in a
rowing child, a limitation that has encouraged us to use the
oss-Konno procedure in patients in whom we are unable to
mplant a valve 21 mm or larger.
In response to your third question, there was indeed a correla-
ion between injury to the pulmonary valve at the time of the
onno operation and the need for late reintervention for pulmo-
ary valve insufficiency. I believe that the pulmonary valve is quite
xposed to injury during the procedure because of the very limited
pace between the right coronary ostia and the lateral commissure
f the aortic valve. In an effort to avoid injury to the coronary
stia, the surgeon places his annular transecting incision as close to
he commissure as possible. Again, this is a specific problem of the
onno operation.
Your fourth question refers to changes in left ventricular ejec-
ion fraction seen after the Konno procedure. I believe this might
e the effect of early paradoxic movement of the patch, which may
mprove with time as the patch stiffens. We have seen this in
atients undergoing the Rastelli procedure, in whom a similarly
laced patch can cause the same phenomenon.
Dr Hillel Laks (Los Angeles, Calif ). I enjoyed this presentation
ery much, and I just wanted to ask you about the failure of the
rosthetic aortic valves. What we have seen in younger children
nd adolescents, possibly because of their ability to create pseudo- e
The Journal of Thoracicntima much more than adults, is that although we are talking to
heir families about a potential curative operation with a permanent
alve, in fact a very big percentage, even with adequately sized
alves for their body size, are coming back with a pannus below
he valve, which is part of the obstruction, and I wondered whether
ou had seen that and whether it wasn’t altogether a body mis-
atch but also some pannus embedded in the Konno because of
he proximity to the Dacron polyester fabric graft, whether that
erhaps exaggerates the pannus ingrowth?
Dr Puga. Yes, indeed, we have seen in many of these reop-
rations an excessive amount of scarring at the point of implan-
ation to the septum and under the valve. Pannus formation is
articularly likely to cause problems in patients who bear small
rostheses.
Dr Richard A. Jonas (Washington, DC). I agree that if you do
n aggressive enlargement with a Konno procedure anteriorly that you
un a risk that you are either going to impinge on the pulmonary valve
r the right coronary. What about the option of combining an
nterior enlargement with a Konno and a posterior enlargement
ith a Manouguian, which seems to me to be more symmetrical?
e have been moving toward using more combined Manouguian-
onno type procedures rather than an ultra-aggressive Konno
rocedure.
Dr Puga. I would agree with that. I have done a procedure in
hich a Konno was done with a miniroot autograft, implanting
oth coronaries and enlarging the site of implantation both poste-
iorly and anteriorly. That indeed may be another option for the
rocedure to avoid having to enlarge the outflow tract anteriorly so
xtensively.
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DABLE E1. Indications for operation
ndication No. %
ultilevel LVOTO 23 43
unnel subaortic stenosis 18 34
S, AR, hypoplasia 12 23
VOTO, Left ventricular outflow tract obstruction; AS, aortic stenosis; AR,
ortic regurgitationv
The Journal of Thoracic anABLE E2. Konno operation
omponent No. %
alve
Mechanical 40 75
Homograft 10 19
Xenograft 3 6
eptal patch
Dacron 30 57
Meadox 7 13
Homograft 7 13
Pericardium 4 8
Tascon 4 8
Gore-Tex 1 2
ight ventricular patch
Pericardium 39 74
Dacron 4 8
Meadox 4 8
Tascon 3 6
Homograft 2 4
Primary closure 1 2
ther
MVR 4 8
MV repair 3 6
TV repair 2 4
VSD closure 2 4
CABG 2 4
Permanent pacemaker 1 2
ypass (min, median and range) 173 (75-327)
rossclamp (min, median and range) 114 (54-234)
onfatal complications
Heart block 6 11
Sepsis 2 4
Bleeding 1 2
Respiratory failure 1 2
Renal failure 1 2
VR, Mitral valve replacement; MV, mitral valve; TV, tricuspid valve; VSD,
entricular septal defect; CABG, coronary artery bypass grafting.
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DABLE E3. Indications for reoperation
ndication No. %
ortic
Valve stenosis 6 11
Valve regurgitation 5 9
Endocarditis 3 6
ther
VSD 3 6
Pulmonary valve replacement 3 6
Mitral valve replacement 2 4
Tricuspid valve replacement 2 4
Heart transplant 1 2SD, Ventricular septal defect.
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